Modification of Sample Size in Group Sequential Clinical Trials (Q4666658): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q47213272, #quickstatements; #temporary_batch_1712201099914 |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Discrete Sequential Boundaries for Clinical Trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Stochastically curtailed tests in long–term clinical trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Designed Extension of Studies Based on Conditional Power / rank | |||
Normal rank | |||
Revision as of 19:34, 7 June 2024
scientific article; zbMATH DE number 2155936
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modification of Sample Size in Group Sequential Clinical Trials |
scientific article; zbMATH DE number 2155936 |
Statements
Modification of Sample Size in Group Sequential Clinical Trials (English)
0 references
13 April 2005
0 references
interim analysis
0 references
power
0 references
sample size
0 references
type I error
0 references
0 references
